January 2025 FDA Recall Drug by Remedyrepack Inc.
D-0217-2025 - CGMP deviations

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on January 24, 2025 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in FL and the recall is currently terminated.

Recall Number: D-0217-2025

Reason for Recall
CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
Initiated
01-24-2025
Reported
02-12-2025
Quantity
247 blister packs

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.

Batch or Lot Expiration Information

Lot# s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.